(Press-News.org) Free genetic testing, offered partially or fully subsidized by industry, may have trade-offs, and health systems in Canada must carefully weigh potential clinical, ethical, and legal considerations to protect patient data, authors argue in a CMAJ (Canadian Medical Association Journal) commentary https://www.cmaj.ca/lookup/doi/10.1503/cmaj.231588.
“Near- and long-term expansion in no-cost testing and industry partnership in genetics, with patient data as the commodity, is likely,” writes Kirsten Bartels, a genetic counsellor at Providence Health Care Heart Centre, St. Paul’s Hospital, Vancouver, British Columbia, with coauthors. “Commodification of data is not the norm in health care systems in Canada and should not be introduced without due consideration.”
Sponsored genetic testing is available for a variety of conditions, from neuromuscular to eye conditions, and must be ordered by a medical professional, like provincially funded genetic tests. Most of these sponsored tests are performed in the United States, and technologies and testing methods may differ from those used in Canada, with potentially different or incomplete results. Sponsored genetic testing can also include a wider range of genes for testing, which may cause additional harm.
As well, Canada has stringent privacy laws to protect patients, but these laws may not apply in countries where testing is conducted, which could leave patients vulnerable to being identified.
To help guide health care providers in Canada about using sponsored genetic testing, the commentary authors, as members of the Canadian College of Medical Geneticists and Canadian Association of Genetic Counsellors, recently published a position statement.
They end with a call to action for government and health organizations.
“We call on health care jurisdictions to consider this important issue urgently and to support the development of comprehensive guidance to help practitioners navigate this next generation of genetic testing and data sharing.”
END
Is free genetic testing really free?
2024-07-29
ELSE PRESS RELEASES FROM THIS DATE:
Health: Short-term vegan diet associated with reductions in biological age estimates
2024-07-29
Eating a vegan diet for eight weeks is associated with reductions in biological age estimations based on levels of DNA methylation — a type of chemical modification of DNA (known as an epigenetic modification) that alters gene expression but not DNA itself. Previous research has reported that increased DNA methylation levels are associated with ageing. The findings, which are based on a small randomised controlled trial of 21 pairs of adult identical twins, are published in BMC Medicine.
Varun Dwaraka, Christopher ...
Evidence-based information combats misleading and false claims on the internet and social media about the anti-Mullerian hormone test
2024-07-29
Researchers in Australia have found that when women are given accurate information about a test that indicates the number of eggs in their ovaries, they have less interest in taking the test compared to women who viewed information available online.
The researchers initiated the study, which is published today (Monday) in Human Reproduction [1], one of the world’s leading reproductive medicine journals, because of the large amount of misleading and incorrect information promoted to women about the anti-Mullerian hormone (AMH) test on websites, including fertility clinic websites, and via social media.
AMH ...
Steel industry’s net zero drive could make lower-grade iron ore viable
2024-07-29
A decarbonised steel industry that includes carbon dioxide removal techniques in its net zero arsenal could use lower-grade iron ore, according to a new study.
Steel accounts for 5-8% of carbon dioxide emissions globally. Its total emissions have risen over the past decade, largely due to increased demand.
The International Energy Agency has stated that, without innovation, the scope to limit emissions is ‘limited’. Therefore, the commercialisation of new zero-emission production processes is critical.
Innovative ...
Plasma phosphorylated tau 217 and Aβ42/40 to predict early brain Aβ accumulation in people without cognitive impairment
2024-07-28
About The Study: The results of this cohort study suggest that combining plasma p-tau217 and Aβ42/40 levels could be useful for predicting development of Aβ pathology in people with early stages of subthreshold Aβ accumulation. These biomarkers might thus facilitate screening of participants for future primary prevention trials.
Corresponding Authors: To contact the corresponding authors, email Oskar Hansson, M.D, Ph.D. (Oskar.Hansson@med.lu.se) and Shorena Janelidze, Ph.D. (shorena.janelidze@med.lu.se).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2024.2619)
Editor’s ...
MRI signature of α-synuclein pathology in asymptomatic stages and a memory clinic population
2024-07-28
About The Study: In this cohort study, seed amplification assays (SAA) α-syn+ was consistently associated with nucleus basalis of Meynert (NBM) atrophy already during asymptomatic stages. Further, in memory clinic cognitively impaired populations, SAA α-syn+ was associated with NBM atrophy, which partially mediated α-syn–induced attention/executive impairment.
Corresponding Authors: To contact the corresponding authors, email Laura E.M. Wisse, Ph.D. (laura.wisse@med.lu.se) and Oskar Hansson, M.D., Ph.D. (oskar.hansson@med.lu.se).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2024.2713)
Editor’s ...
Blood biomarkers to detect Alzheimer disease in primary care and secondary care
2024-07-28
About The Study: The amyloid probability score 2 (APS2) blood test and percentage of p-tau217 alone had high diagnostic accuracy for identifying Alzheimer disease among individuals with cognitive symptoms in primary and secondary care using predefined cutoff values. Future studies should evaluate how the use of blood tests for these biomarkers influences clinical care.
Corresponding Authors: To contact the corresponding authors, email Sebastian Palmqvist, M.D., Ph.D. (sebastian.palmqvist@med.lu.se) and Oskar Hansson, M.D., Ph.D. (oskar.hansson@med.lu.se).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.13855)
Editor’s ...
Changes in Alzheimer disease blood biomarkers and associations with incident all-cause dementia
2024-07-28
About The Study: Plasma biomarkers of Alzheimer disease (AD) neuropathology, neuronal injury, and astrogliosis increase with age and are associated with known dementia risk factors. AD-specific biomarkers’ association with dementia starts in midlife whereas late-life measures of AD, neuronal injury, and astrogliosis biomarkers are all associated with dementia.
Corresponding Author: To contact the corresponding author, Priya Palta, Ph.D., M.H.S., email priya_palta@med.unc.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.6619)
Editor’s ...
New and improved drug delivery molecules for skeletal muscle
2024-07-27
Tokyo, Japan – Researchers from Tokyo Metropolitan University have created a new drug delivering molecule, a zwitterionic polymer complex that can help get plasmid DNA inside cells when injected into skeletal muscle, a crucial step in the expression of therapeutic RNA and proteins. The new compound effectively bound to plasmid DNA without affecting its structure. Injected into mouse muscles, the team observed widespread gene expression, promising applications to treatments of serious muscle diseases.
Drug delivery systems underpin many of the clinical breakthroughs of our age. For example, ...
UC San Diego Health ends negotiations with Tri-City Medical Center Healthcare District
2024-07-27
UC San Diego Health has ended more than nine months of negotiations for a potential partnership with the Tri-City Medical Center (TCMC) Healthcare District.
A final revised offer was presented to the TCMC Healthcare District on July 24 and no agreement was reached.
Highlights of the final proposal for TCMC included a financial recovery and growth plan that included:
$100 million infusion of cash within the first two years plus other financial supports, including a line of credit designed to protect the financial stability of TCMC during the first five years.
All assets and liabilities would transfer to UC San Diego Health, including employment ...
MLB add lifesavers to the chain of survival in New York City
2024-07-27
NEW YORK CITY, July 26, 2024 — The American Heart Association and Major League Baseball (MLB) brought cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) training to MLB staff at the New York headquarters office located on Avenue of the Americas on Monday, July 22. Nearly 100 employees attended to learn the lifesaving skills building confidence and capabilities to respond in the event of a cardiac emergency. According to American Heart Association data, nine out of every ten people who experience cardiac arrest outside of a hospital die, in part because they do not receive immediate CPR more than half of the time. CPR, especially if performed ...